• DOI:10.7326/M13-2844
Corpus ID: 33835367

Low-Dose Aspirin for Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force

@article{Henderson2014LowDoseAF,
  title={Low-Dose Aspirin for Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force},
  author={J. Henderson and E. Whitlock and E. O'connor and Caitlyn A. Senger and J. Thompson and Maya G Rowland},
  journal={Annals of Internal Medicine},
  year={2014},
  volume={160},
  pages={695-703}
}

J. Henderson, E. Whitlock, +3 authors Maya G Rowland

Published 2014

Medicine

Annals of Internal Medicine

Preeclampsia is a leading cause of maternal death, affecting 2% to 8% of pregnancies globally (1, 2). It affected 3.8% of U.S. deliveries in 2010, and the rate of severe preeclampsia has increased over the past 3 decades (3). Perinatal mortality is nearly 2 times higher in pregnancies affected by preeclampsia (4), with 12% of maternal deaths due to the condition (5). Serious illness is more common, with more than one third of serious maternal morbidity and 15% of preterm births related to… CONTINUE READING

View on PubMed

doi.org

Save to Library

Create Alert

Cite

Launch Research Feed